000			01419nam a22002777a 4500
001			sulb0073998
003			BD-SySUS
005			20200907113602.0
008			200907s2018 nyu 000 0 eng d
020			_a9780815345565
040			_aDLC _beng _erda _cDLC _dDLC _dBD-SySUS
082	0	0	_a615.19 _223 _bDUM
100	1		_aDunlap, Norma, _eauthor. _934258
245	1	0	_aMedicinal chemistry / _cNorma Dunlap, Donna M. Huryn.
263			_a1712
264		1	_aNew York , NY : _bGarland Science, Taylor & Francis Group, LLC, _c[2018]
300			_apages cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
505	0		_aHistorical perspective and overview of drug discovery -- Drug discovery: hit and lead discovery -- Drug discovery: optimization of lead properties -- Medicinal chemistry strategies used in lead optimization -- The process of developing a drug from an optimized lead: -- Receptors as drug targets -- Enzymes as drug targets -- Protein-protein interactions and lipids as drug targets -- DNA and RNA as drug targets -- Anti-cancer drugs -- Infectious diseases I: antiviral and antifungal drugs -- Infectious diseases II: antibacterial and antiparasitic drugs -- Drugs acting on the CNS.
650		0	_aPharmaceutical chemistry. _936393
650		0	_aChemotherapy. _936394
700	1		_aHuryn, Donna M., _eauthor. _934263
942			_2ddc _cBK
999			_c75441 _d75441